NeuroDerm CEO to Present at the 35th Annual J.P. Morgan Healthcare Conference on January 12, 2017
Jan 03, 2017 12:01 pm UTC| Business
REHOVOT, Israel, Jan. 03, 2017 -- NeuroDerm Ltd. (Nasdaq:NDRM), a clinical stage pharmaceutical company developing drugs for central nervous system (CNS) diseases, today announced that CEO Oded S. Lieberman, PhD will...
LHC Group and LifePoint Health Collaborate to Enhance Home Health and Hospice Services Nationwide
Jan 03, 2017 12:01 pm UTC| Business
LAFAYETTE, La. and BRENTWOOD, Tenn., Jan. 03, 2017 -- LHC Group, Inc. (NASDAQ:LHCG) and LifePoint Health® (NASDAQ:LPNT) have finalized the formation of a joint venture that will strengthen home health and hospice...
LHC Group and LifePoint Health Collaborate to Enhance Home Health and Hospice Services Nationwide
Jan 03, 2017 12:01 pm UTC| Business
LAFAYETTE, La. and BRENTWOOD, Tenn., Jan. 03, 2017 -- LHC Group, Inc. (NASDAQ:LHCG) and LifePoint Health® (NASDAQ:LPNT) have finalized the formation of a joint venture that will strengthen home health and hospice...
Jan 03, 2017 12:01 pm UTC| Business
OMER, Israel, Jan. 03, 2017 -- Medigus Ltd. (NASDAQ:MDGS) (TASE:MDGS), a medical device company developing minimally invasive endosurgical tools and a leader in direct visualization technology, announced today that...
Jan 03, 2017 12:01 pm UTC| Business
OMER, Israel, Jan. 03, 2017 -- Medigus Ltd. (NASDAQ:MDGS) (TASE:MDGS), a medical device company developing minimally invasive endosurgical tools and a leader in direct visualization technology, announced today that...
Voyager Therapeutics Appoints Jane Pritchett Henderson as Chief Financial Officer
Jan 03, 2017 12:01 pm UTC| Business
CAMBRIDGE, Mass., Jan. 03, 2017 -- Voyager Therapeutics, Inc. (NASDAQ:VYGR), a clinical-stage gene therapy company developing life-changing treatments for severe diseases of the central nervous system (CNS), today...
Voyager Therapeutics Appoints Jane Pritchett Henderson as Chief Financial Officer
Jan 03, 2017 12:01 pm UTC| Business
CAMBRIDGE, Mass., Jan. 03, 2017 -- Voyager Therapeutics, Inc. (NASDAQ:VYGR), a clinical-stage gene therapy company developing life-changing treatments for severe diseases of the central nervous system (CNS), today...